Assignee
ADMARE THERAPEUTICS SOC
CA·0 granted patents·5 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
5 records- 0160US2024239790A17-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 0260US2024246960A17-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 0354US2025326754A1DNA-PK Inhibitor Compounds and Uses ThereofADMARE THERAPEUTICS SOC·Filed 2023·Application pending·0 cites
- 0447US2024309070A1Anti-vaccinia virus antigen antibodies and related compositions and methodsADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 0546US2023027475A1Anti-oncolytic virus antigen antibodies and methods of using sameADMARE THERAPEUTICS SOC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →